Onyx Healthcare Inc. (TPEX:6569)
100.00
-1.50 (-1.48%)
Apr 20, 2026, 1:15 PM CST
Onyx Healthcare Market Cap
Onyx Healthcare has a market cap or net worth of 3.97 billion as of April 17, 2026. Its market cap has decreased by -34.40% in one year.
Market Cap
3.97B
Enterprise Value
3.88B
Revenue
1.31B
Ranking
n/a
PE Ratio
35.37
Stock Price
100.00
Market Cap Chart
Since January 15, 2016, Onyx Healthcare's market cap has increased from 1.94B to 3.97B, an increase of 104.79%. That is a compound annual growth rate of 7.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 3.97B | -7.31% |
| Dec 31, 2025 | 4.28B | -27.59% |
| Dec 31, 2024 | 5.91B | 2.52% |
| Dec 29, 2023 | 5.76B | 77.16% |
| Dec 30, 2022 | 3.25B | 2.87% |
| Dec 30, 2021 | 3.16B | -11.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 242.37B |
| Caliway Biopharmaceuticals | 168.09B |
| Lotus Pharmaceutical | 61.63B |
| Heron Neutron Medical | 61.19B |
| Sagittarius Life Science | 4.19B |
| Orient EuroPharma | 4.11B |
| Bonraybio | 4.09B |
| ACRO Biomedical | 4.09B |